ELIZABETH MURRAY: Open Payments
NPI 1538760350 · GREER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,126 in 99 payments from 21 companies in 2025. Trend: 2023 $932 · 2024 $839 · 2025 $2,126
Food & beverage: $2,042Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $583 |
| Janssen Biotech, Inc. | 20 | $341 |
| Ardelyx, Inc. | 9 | $203 |
| QOL Medical, LLC | 5 | $153 |
| Madrigal Pharmaceuticals | 6 | $141 |
| Gilead Sciences, Inc. | 5 | $120 |
| Braintree Laboratories, Inc. | 4 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $73 |
| Ipsen Biopharmaceuticals, Inc | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $57 |
Products named: TREMFYA, RINVOQ, IBSRELA, Sucraid, REZDIFFRA, SKYRIZI, LINZESS, CREON.
Industry payments across SC — which companies pay providers there.
